BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19812898)

  • 1. A highly effective and long-lasting inhibition of miRNAs with PNA-based antisense oligonucleotides.
    Oh SY; Ju Y; Park H
    Mol Cells; 2009 Oct; 28(4):341-5. PubMed ID: 19812898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent.
    Oh SY; Ju Y; Kim S; Park H
    Oligonucleotides; 2010 Oct; 20(5):225-30. PubMed ID: 20946011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide nucleic acids (PNAs) antisense effect to bacterial growth and their application potentiality in biotechnology.
    Hatamoto M; Ohashi A; Imachi H
    Appl Microbiol Biotechnol; 2010 Mar; 86(2):397-402. PubMed ID: 20135118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.
    Kaihatsu K; Huffman KE; Corey DR
    Biochemistry; 2004 Nov; 43(45):14340-7. PubMed ID: 15533038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifunctional small molecule-oligonucleotide hybrid as microRNA inhibitor.
    Bhattarai U; Hsieh WC; Yan H; Guo ZF; Shaikh AY; Soltani A; Song Y; Ly DH; Liang FS
    Bioorg Med Chem; 2020 Apr; 28(7):115394. PubMed ID: 32139203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.
    Torres AG; Threlfall RN; Gait MJ
    Artif DNA PNA XNA; 2011; 2(3):71-8. PubMed ID: 22567190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved targeting of miRNA with antisense oligonucleotides.
    Davis S; Lollo B; Freier S; Esau C
    Nucleic Acids Res; 2006; 34(8):2294-304. PubMed ID: 16690972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.
    Fabani MM; Gait MJ
    RNA; 2008 Feb; 14(2):336-46. PubMed ID: 18073344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
    Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
    Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
    Gambari R
    Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-Generation Peptide Nucleic Acid Chimeras Exhibit High Affinity and Potent Gene Silencing.
    Debacker AJ; Sharma VK; Meda Krishnamurthy P; O'Reilly D; Greenhill R; Watts JK
    Biochemistry; 2019 Feb; 58(6):582-589. PubMed ID: 30520300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics.
    Pradeep SP; Malik S; Slack FJ; Bahal R
    RNA; 2023 Apr; 29(4):434-445. PubMed ID: 36653113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of microRNA in vivo without degradation.
    Davis S; Propp S; Freier SM; Jones LE; Serra MJ; Kinberger G; Bhat B; Swayze EE; Bennett CF; Esau C
    Nucleic Acids Res; 2009 Jan; 37(1):70-7. PubMed ID: 19015151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Suitable Carrier Molecules and Target Genes for Antisense Therapy Using Peptide-Coupled Peptide Nucleic Acids (PNAs) in Streptococci.
    Barkowsky G; Kreikemeyer B; Patenge N
    Methods Mol Biol; 2020; 2136():339-345. PubMed ID: 32430835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
    Liu Y; Braasch DA; Nulf CJ; Corey DR
    Biochemistry; 2004 Feb; 43(7):1921-7. PubMed ID: 14967032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and off-target prediction for antisense oligomers targeting bacterial mRNAs with the MASON web server.
    Jung J; Popella L; Do PT; Pfau P; Vogel J; Barquist L
    RNA; 2023 May; 29(5):570-583. PubMed ID: 36750372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers.
    Shiraishi T; Nielsen PE
    Artif DNA PNA XNA; 2011; 2(3):90-9. PubMed ID: 22567192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts.
    Penolazzi L; Borgatti M; Lambertini E; Mischiati C; Finotti A; Romanelli A; Saviano M; Pedone C; Piva R; Gambari R
    Int J Mol Med; 2004 Aug; 14(2):145-52. PubMed ID: 15254756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain.
    Karras JG; Maier MA; Lu T; Watt A; Manoharan M
    Biochemistry; 2001 Jul; 40(26):7853-9. PubMed ID: 11425312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short pyrimidine stretches containing mixed base PNAs are versatile tools to induce translation elongation arrest and truncated protein synthesis.
    Sénamaud-Beaufort C; Leforestier E; Saison-Behmoaras TE
    Oligonucleotides; 2003; 13(6):465-78. PubMed ID: 15025913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.